Doctors paid to advice, promote drug companies that fund their research
March 25, 2014
Research has been seen as less objectionable than other forms of interactions with drug companies, but 10 percent of researchers have multiple ties among the nine companies ProPublica analysed. That raises questions about doctors’ impartiality
Charles Ornstein and Ryann Grochowski Jones (ProPublica)
Pharmaceutical companies pay for the clinical trials that Dr. Yoav Golan conducts on antibiotics at Tufts Medical Center.
.jpg "MoneyLife")
